Evidence map›Paper›PMID 36969249›Full record

ArticleFrontiers in immunology2023

Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: A bidirectional Mendelian randomization study.

Yu-Feng Huang, Wei-Ming Zhang, Zhi-Song Wei, Huan Huang, Qi-Yan Mo, Dan-Li Shi, Lu Han, Yu-Yuan Han, Si-Kai Nong, Guo-Xiang Lin

Full text read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu-Feng HuangThe First Clinical College, Shanxi Medical University, Jinzhong, China.
Wei-Ming ZhangDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Zhi-Song WeiDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Huan HuangDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Qi-Yan MoDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Dan-Li ShiDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Lu HanDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Yu-Yuan HanDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Si-Kai NongDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Guo-Xiang LinDepartment of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple clinical studies have indicated that the gut microbiota influences the effects of immune checkpoint blockade (ICB) therapy comprising PD-1/PD-L1 inhibitors, but the causal relationship is unclear. Because of numerous confounders, many microbes related to PD-1/PD-L1 have not been identified. This study aimed to determine the causal relationship between the microbiota and PD-1/PD-L1 and identify possible biomarkers for ICB therapy. Method: We used bidirectional two-sample Mendelian randomization with two different thresholds to explore the potential causal relationship between the microbiota and PD-1/PD-L1 and species-level microbiota GWAS to verify the result. Result: In the primary forward analysis, genus_Holdemanella showed a negative correlation with PD-1 [βIVW = -0.25; 95% CI (-0.43 to -0.07); P

Indexed as

B7-H1 AntigenGastrointestinal MicrobiomeApoptosisLigandsMendelian Randomization AnalysisProgrammed Cell Death 1 ReceptorB7-H1 AntigenLigandsProgrammed Cell Death 1 Receptorbidirectional Mendelian randomizationcausalitygut microbiotaPD-1/PD-L1pQTL

Identifiers

PMID36969249
PMCPMC10034163

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read32
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.